Cogene Ventures, a Texas-based venture capital firm, specializes in early-, mid-, expansion-, and late-stage investments.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 8, 2006
Neuromed Pharmaceuticals
|
Series D | $25M | Biopharma | — |
Oct 24, 2005
Raven Biotechnologies
|
Series D | $48.30M | Biotechnology | — |
Oct 15, 2004
MacroGenics
|
Series B | $30.50M | Biotechnology | — |
Jun 23, 2004
Rejuvenon
|
Series B | $37M | Biotechnology | — |
Mar 1, 2004
TransMolecular
|
Series C | $33.20M | Biotechnology | — |
Cogene Ventures has had 5 exits. Cogene Ventures most notable exits include MacroGenics , TransMolecular
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 10, 2013 | MacroGenics | IPO | Biotechnology | Detail |
Mar 4, 2011 | TransMolecular | M&A | Biotechnology | Detail |
Dec 21, 2009 | Neuromed Pharmaceuticals | M&A | Biopharma | Detail |
Jul 17, 2008 | Raven Biotechnologies | M&A | Biotechnology | Detail |
Apr 21, 2006 | Catalyst Bioscience | IPO | Biotechnology | Detail |